Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
CAPNETZ
- Overall study
Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
---|---|---|---|---|
CAPNETZ: Community Acquired Pneumonia NETZwerk
Status: Active
Purpose / Objectives
Diagnosis
- HIV-1
- Pneumonie (ambulant erworben) (English name missing)
Target population
Age
18-99
Study design
- Multicenter
- Prospective
- Two-arm
Intervention
NA
Documents (password protected)
Responsibilities in overall study
Sponsor
MHH - Medizinische Hochschule Hannover
- Tel. +49 511 532-3556
- Fax +49 511 532-3481
Project management
MHH - Medizinische Hochschule Hannover
- Tel. +49 511 532-3556
- Fax +49 511 532-3481
Monitoring
MHH - Medizinische Hochschule Hannover
- Tel. +49 511 532-3556
- Fax +49 511 532-3481